GO:0008190 eukaryotic initiation factor 4E binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008190 (eukaryotic initiation factor 4E binding) is a molecular function describing the selective binding of proteins to eIF4E, the cap-binding subunit of the translation initiation complex.
• The best-characterized eIF4E-binding proteins are the 4E-BPs, which compete with eIF4G for a shared surface on eIF4E and thereby repress cap-dependent translation.
• Phosphorylation of eIF4E and of 4E-BP1 acts as a switch that controls whether eIF4E binds 4E-BP1 or assembles into the eIF4F cap-binding complex.
• eIF4E binding is regulated by nutrient- and growth-factor-sensitive pathways, most notably mTORC1 signaling, linking translation control to cell growth and tumorigenesis.
• Dysregulated eIF4E binding contributes to cancer, and eIF4E itself is a validated target for small-molecule inhibitors such as benzoxaboroles.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to test which eIF4E-binding interactions are causal in a given biological context.
Description
Eukaryotic initiation factor 4E binding (GO:0008190) is the molecular function of physically associating with eIF4E, the cap-binding protein that nucleates the eIF4F translation initiation complex. eIF4E recognizes the m7G cap at the 5' end of mRNAs and, together with eIF4G and eIF4A, loads the ribosome onto the transcript. Because eIF4E availability is rate-limiting for cap-dependent translation, proteins that bind eIF4E can either deliver it to the ribosome or sequester it away from the translation machinery. The most studied eIF4E-binding proteins are the 4E-BPs, which share a canonical YXXXXL motif with eIF4G and compete for the same dorsal surface of eIF4E. This competition makes GO:0008190 a central node for integrating growth signals with protein synthesis. For researchers, GO:0008190 is important because it defines a druggable and genetically tractable interface. Phosphorylation of eIF4E at Ser209 and phosphorylation of 4E-BP1 at multiple mTORC1 sites modulate the eIF4E-4E-BP1 interaction, providing phospho-switches that can be monitored experimentally. Structural and biochemical studies show that the nucleotide-bound state of eIF4A and the composition of the eIF4F complex influence how eIF4E engages RNA and partner proteins. In skeletal muscle, the distribution of eIF4E after resistance exercise changes with recovery duration, illustrating that eIF4E binding is dynamically remodeled by physiological stimuli. Small molecules such as benzoxaboroles can bind eIF4E directly, confirming that this interface is chemically tractable. This article summarizes the QuickGO definition of GO:0008190, the proteins that carry this function, the mechanisms that regulate it, its links to disease, and the experimental methods, including CRISPR-based models, used to study it. All statements are anchored to the verified literature cited by number.
eukaryotic initiation factor 4E binding At A Glance
| GO ID | GO:0008190 |
|---|---|
| GO term | eukaryotic initiation factor 4E binding |
| Ontology | molecular_function |
| Synonym | eIF4E binding |
| Definition | Binding to eukaryotic initiation factor 4E, a polypeptide factor involved in the initiation of ribosome-mediated translation. |
| Major function | Mediates assembly or repression of the eIF4F cap-binding complex during translation initiation. |
| Representative binders | 4E-BP1/2/3, eIF4G, and other eIF4E-interacting proteins. |
| Key modification | eIF4E Ser209 phosphorylation and 4E-BP1 phosphorylation modulate binding. |
| Upstream regulator | mTORC1 signaling controls 4E-BP1 phosphorylation and eIF4E availability. |
| Disease relevance | Cancer, translation-related growth disorders, and muscle physiology. |
What Is GO:0008190?
GO:0008190, eukaryotic initiation factor 4E binding, is defined in QuickGO as binding to eukaryotic initiation factor 4E, a polypeptide factor involved in the initiation of ribosome-mediated translation. In practice, it is the function of any protein that makes direct physical contact with eIF4E, whether to repress translation (for example, 4E-BP1) or to recruit eIF4E into a larger initiation complex (for example, eIF4G). The synonym eIF4E binding is used interchangeably. Because the term is a molecular function, it is assigned to gene products based on demonstrated binding to eIF4E, not on a downstream phenotype.
Why Is eukaryotic initiation factor 4E binding Important in Cell Biology?
GO:0008190 matters because the eIF4E interaction surface is a convergence point for growth signaling, translation control, and disease. 4E-BP1 is a master regulator of mRNA translation in tumorigenesis, and its ability to bind eIF4E determines whether cap-dependent translation proceeds. Phosphorylation events on eIF4E and 4E-BP1 act as switches for complex assembly, and the nucleotide state of eIF4A further tunes eIF4F binding to RNA. Because eIF4E can be targeted by small molecules, understanding its binding partners has direct therapeutic implications. In physiology, eIF4E distribution after resistance exercise is sensitive to recovery duration, showing that this function is dynamically regulated in vivo.
• Defines the competition between 4E-BPs and eIF4G for eIF4E, which sets the rate of cap-dependent translation.
• Provides a phospho-switch mechanism through eIF4E Ser209 and 4E-BP1 phosphorylation.
• Links mTORC1 nutrient and growth-factor signaling to protein synthesis.
• Is dysregulated in cancer, where elevated eIF4E activity promotes oncogenic translation.
• Is chemically tractable, as shown by benzoxaborole binders of eIF4E.
• Is dynamically remodeled by exercise and recovery in skeletal muscle.
• Is required for eIF4F assembly and mRNA cap recognition.
• Can be studied with phospho-specific antibodies and binding assays.
• Is dispensable for some physiological hypertrophy responses, highlighting context dependence.
• Offers a defined molecular function for CRISPR-based causal testing.
Molecular Mechanism of eukaryotic initiation factor 4E binding
eIF4E structure and the cap-binding surface
In simple terms: eIF4E is the protein that grabs the cap on the front end of an mRNA.
eIF4E is a small cap-binding protein that recognizes the m7G cap structure of eukaryotic mRNAs and serves as the nucleation point for the eIF4F complex. Its dorsal surface, opposite the cap-binding pocket, is the docking site for 4E-BPs and eIF4G. Structural and biochemical work shows that eIF4E function is coupled to the nucleotide-bound state of eIF4A and to eIF4F binding to RNA.
Competitive binding by 4E-BPs and eIF4G
In simple terms: Two different proteins compete for the same spot on eIF4E, and whoever wins decides whether translation starts.
4E-BP1 and eIF4G share a canonical binding motif and compete for an overlapping surface on eIF4E. When 4E-BP1 occupies eIF4E, eIF4G cannot bind and cap-dependent translation is repressed; when 4E-BP1 is phosphorylated and released, eIF4G can engage eIF4E and initiate translation. This competition is the mechanistic core of GO:0008190.
Phosphorylation switches on eIF4E and 4E-BP1
In simple terms: Adding phosphate groups to these proteins flips them between binding and not binding.
Phosphorylation of eIF4E acts as a switch for its binding to 4E-BP1 and for mRNA cap assembly. 4E-BP1 is phosphorylated at multiple sites by mTORC1, which reduces its affinity for eIF4E and liberates eIF4E for eIF4F formation. However, eIF4E phosphorylation is dispensable for skeletal muscle hypertrophy, indicating that not every context requires this modification.
Regulation by mTORC1 and growth signals
In simple terms: Growth signals tell the cell whether to let translation run.
mTORC1 integrates nutrient and growth-factor cues and phosphorylates 4E-BP1, thereby controlling eIF4E availability and the eIF4E-4E-BP1 interaction. This places GO:0008190 downstream of a major signaling hub and explains why eIF4E binding is sensitive to cellular metabolic state.
Dynamic remodeling in physiological contexts
In simple terms: Even exercise changes where eIF4E is and what it binds.
In skeletal muscle, the distribution of eIF4E after bouts of resistance exercise is altered by shortening recovery periods, demonstrating that eIF4E binding is dynamically remodeled by physiological stimuli. Such findings show that GO:0008190 is not a static property but a regulated interaction that can be measured in vivo.
Chemical modulation of eIF4E binding
In simple terms: Drug-like molecules can also stick to eIF4E and change its behavior.
Benzoxaboroles have been identified as structurally unique binders of eIF4E, showing that the eIF4E surface can be engaged by small molecules. This supports the idea that GO:0008190 is a druggable interface and provides chemical tools to probe eIF4E-dependent translation.
Key Genes Involved in GO:0008190 eukaryotic initiation factor 4E binding
The following genes and proteins are the principal carriers or regulators of eukaryotic initiation factor 4E binding (GO:0008190) in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EIF4E | Cap-binding subunit of eIF4F; central binder in GO:0008190 | Core target for translation initiation studies and inhibitor development |
| EIF4EBP1 | 4E-BP1; competes with eIF4G for eIF4E and represses translation | Master regulator of mRNA translation in tumorigenesis |
| EIF4EBP2 | 4E-BP2 family member; eIF4E-binding repressor | Context-dependent translation control |
| EIF4EBP3 | 4E-BP3 family member; eIF4E-binding repressor | Family-level redundancy studies |
| EIF4G1 | Scaffold that binds eIF4E and recruits the ribosome | Defines the activating side of the competition |
| EIF4A1 | RNA helicase in eIF4F; nucleotide state influences eIF4F-RNA binding | Mechanistic studies of complex assembly |
| MTOR | Kinase that phosphorylates 4E-BP1 and controls eIF4E availability | Upstream regulator of GO:0008190 |
| RPTOR | mTORC1 component required for 4E-BP1 phosphorylation | Dissection of mTORC1-dependent translation control |
| RPS6KB1 | p70S6K; mTORC1 effector in translation control | Parallel pathway studies |
| EIF4E1B | eIF4E family member with tissue-specific expression | Family comparison and redundancy |
| EIF4E2 | eIF4E family member (4EHP) | Alternative cap-binding complexes |
| EIF4E3 | eIF4E family member | Family-level binding specificity |
| EIF4H | Helps eIF4A activity in initiation | Complex assembly context |
| EIF4B | Stimulates eIF4A helicase activity | Complex assembly context |
| PABPC1 | Poly(A)-binding protein that interacts with eIF4G | mRNA circularization and initiation |
| MKNK1 | MNK kinase that phosphorylates eIF4E at Ser209 | Phospho-switch studies |
| MKNK2 | MNK family kinase acting on eIF4E | Phospho-switch studies |
How Is eukaryotic initiation factor 4E binding Regulated?
Eukaryotic initiation factor 4E binding is regulated primarily by phosphorylation. mTORC1 phosphorylates 4E-BP1 at multiple sites, reducing its affinity for eIF4E and allowing eIF4G to assemble the eIF4F complex. eIF4E phosphorylation acts as a switch for its binding to 4E-BP1 and for mRNA cap assembly, although this modification is dispensable for skeletal muscle hypertrophy, indicating context-specific requirements. The nucleotide-bound state of eIF4A also regulates eIF4F binding to RNA, adding a layer of control at the complex level. Physiologically, recovery duration after resistance exercise alters eIF4E distribution, showing that regulation extends beyond cell-culture models.
eukaryotic initiation factor 4E binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EIF4EBP1 | Tumorigenesis and translation deregulation | EIF4EBP1 knockout and phospho-mutant knock-in cancer cell lines |
| EIF4E | Oncogenic translation; drug targeting | EIF4E overexpression and point-mutant models with benzoxaborole treatment |
| EIF4E | Skeletal muscle hypertrophy signaling | Muscle-specific knockout and Ser209 point-mutant models |
| MTOR | mTORC1-dependent translation control | MTOR knockout and rapamycin-treated models |
| EIF4A1 | eIF4F assembly and RNA binding | EIF4A1 nucleotide-state mutants and binding assays |
Cancer and oncogenic translation
4E-BP1 is a master regulator of mRNA translation involved in tumorigenesis, and its phosphorylation status determines whether eIF4E is available for cap-dependent translation of oncogenic mRNAs. Because eIF4E binding sits at the interface between mTORC1 signaling and translation, perturbations in this function can promote proliferative and survival programs. eIF4E itself is a validated target, and benzoxaborole binders demonstrate that the eIF4E surface can be engaged pharmacologically.
Muscle physiology and hypertrophy
In skeletal muscle, eIF4E phosphorylation is dispensable for hypertrophy, indicating that not all anabolic responses require this modification. The distribution of eIF4E after resistance exercise is altered by shortening recovery periods, linking eIF4E binding dynamics to exercise adaptation. These findings position GO:0008190 as a node in muscle plasticity research.
Translation-related growth and metabolic disorders
Because mTORC1 controls 4E-BP1 phosphorylation and eIF4E availability, conditions with altered mTORC1 signaling are expected to perturb eIF4E binding. The eIF4F complex, including eIF4E, eIF4G and eIF4A, is the functional unit whose assembly depends on this binding function. Dysregulation of cap-dependent translation is therefore a plausible contributor to growth and metabolic phenotypes.
From eukaryotic initiation factor 4E binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is EIF4EBP1 required for repression of cap-dependent translation? | EIF4EBP1 knockout cell line |
| Does eIF4E Ser209 phosphorylation control 4E-BP1 binding? | EIF4E Ser209 point-mutation knock-in |
| Which eIF4E surface residues mediate 4E-BP1 versus eIF4G binding? | Structure-guided point mutations in EIF4E |
| Can tagged eIF4E report complex dynamics in live cells? | Tagged knock-in of EIF4E |
| Does eIF4E overexpression drive oncogenic translation? | EIF4E overexpression models |
| Is eIF4E phosphorylation required for muscle hypertrophy? | Muscle-specific EIF4E point-mutant knock-in |
How to Study the eukaryotic initiation factor 4E binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Physical interaction between eIF4E and partners | Detecting 4E-BP1 or eIF4G binding |
| Cap-analog pull-down | Cap-binding competence of eIF4E complexes | Assessing eIF4F assembly |
| Phospho-specific western blot | Phosphorylation of eIF4E and 4E-BP1 | Monitoring mTORC1-dependent switches |
| Ribo-seq | Ribosome occupancy and translation efficiency | Global consequences of eIF4E binding |
| Polysome profiling | Distribution of mRNAs across polysomes | Translation initiation changes |
| Phosphoproteomics | Site-specific phosphorylation changes | Pathway-wide analysis of eIF4E regulation |
| Live-cell imaging | Subcellular localization of eIF4E | Dynamic remodeling after exercise or stimuli |
| Surface plasmon resonance | Direct binding affinity of eIF4E-ligand interactions | Small-molecule and peptide binding studies |
Binding assays for eIF4E interactions
Co-immunoprecipitation, pull-down with cap analogs, and far-western assays can detect direct eIF4E binding to 4E-BP1 or eIF4G. Phospho-specific antibodies against eIF4E Ser209 and 4E-BP1 sites allow correlation of modification state with binding. These assays are the primary readout for GO:0008190.
Translation profiling by Ribo-seq and polysome analysis
Ribosome profiling and polysome fractionation measure the consequence of eIF4E binding on mRNA translation efficiency. Because eIF4E binding controls cap-dependent initiation, changes in the eIF4E-4E-BP1 axis are expected to shift ribosome occupancy on sensitive transcripts.
Phosphoproteomics and signaling analysis
Mass spectrometry-based phosphoproteomics can quantify eIF4E and 4E-BP1 phosphorylation states across conditions, linking mTORC1 activity to eIF4E binding. Western blotting with phospho-specific antibodies remains the standard validation method.
Imaging and subcellular localization
Fluorescence imaging of tagged eIF4E can reveal its distribution and redistribution after stimuli such as resistance exercise. Co-localization with eIF4G or 4E-BP1 markers provides spatial information about where binding occurs.
How CRISPR Can Be Used to Study GO:0008190 eukaryotic initiation factor 4E binding
Knockout
CRISPR knockout of EIF4EBP1, EIF4E, or MTOR can test which components are required for eIF4E binding-dependent translation. Knockout of 4E-BP1 is expected to liberate eIF4E and increase cap-dependent translation, providing a clean genetic test of the competition model. Knockout models also help distinguish family-member redundancy among 4E-BP1, 4E-BP2 and 4E-BP3.
Point Mutation
Point mutations in EIF4E at the 4E-BP1/eIF4G interface or at Ser209 can dissect which residues and modifications control binding. Such mutants are valuable because eIF4E phosphorylation is dispensable in some contexts, so residue-level tests clarify context dependence. Point-mutant knock-in of 4E-BP1 phospho-sites can similarly test mTORC1-dependent release from eIF4E.
Knock-in
Tagged knock-in of EIF4E or EIF4EBP1 enables endogenous-level tracking of complex formation and localization without overexpression artifacts. Knock-in of phospho-mimetic or phospho-dead alleles allows stable interrogation of the phosphorylation switch in vivo. These models are particularly useful for physiological studies such as exercise recovery.
Overexpression
Overexpression of EIF4E or of non-phosphorylatable 4E-BP1 can drive or repress cap-dependent translation and reveal downstream phenotypes. Overexpression systems are also used to produce protein for structural and small-molecule binding studies of eIF4E. Combining overexpression with CRISPR knockout of endogenous partners provides a powerful epistasis design.
How EDITGENE Supports eukaryotic initiation factor 4E binding Research
Researchers studying eukaryotic initiation factor 4E binding-related genes often need to determine whether a candidate gene is causally involved in translation control, whether a specific residue or phosphorylation site mediates binding, and whether the interaction can be modulated therapeutically. Answering these questions requires precise, isogenic cell models in which the eIF4E interaction surface or its regulators are altered without confounding artifacts.
Contact EDITGENE today to design your custom CRISPR model for eukaryotic initiation factor 4E binding research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| OTX2 Knockout HEK293 Cell Line | EDJ-KQ989 | Human | 5015 | Details Get a Quote |
| EIF4EBP1 Knockout HEK293 Cell Line | EDJ-KQ1177 | Human | 1978 | Details Get a Quote |
| LARP1 Knockout HEK293 Cell Line | EDJ-KQ2425 | Human | 23367 | Details Get a Quote |
| EIF4EBP2 Knockout HEK293 Cell Line | EDJ-KQ4512 | Human | 1979 | Details Get a Quote |
| HHEX Knockout HEK293 Cell Line | EDJ-KQ4865 | Human | 3087 | Details Get a Quote |
| ANGEL1 Knockout HEK293 Cell Line | EDJ-KQ7986 | Human | 23357 | Details Get a Quote |
| C8orf88 Knockout HEK293 Cell Line | EDJ-KQ12639 | Human | 100127983 | Details Get a Quote |
| LARP1 Knockout HCT 116 Cell Line | EDJ-KQ22935 | Human | 23367 | Details Get a Quote |
| LARP1 Knockout HeLa Cell Line | EDJ-KQ22936 | Human | 23367 | Details Get a Quote |
| EIF4EBP2 Knockout A-549 Cell Line | EDJ-KQ27121 | Human | 1979 | Details Get a Quote |
| EIF4EBP2 Knockout HCT 116 Cell Line | EDJ-KQ27122 | Human | 1979 | Details Get a Quote |
| EIF4EBP2 Knockout HeLa Cell Line | EDJ-KQ27123 | Human | 1979 | Details Get a Quote |
| EIF4EBP1 Knockout A-549 Cell Line | EDJ-KQ20448 | Human | 1978 | Details Get a Quote |
| EIF4EBP1 Knockout HCT 116 Cell Line | EDJ-KQ20449 | Human | 1978 | Details Get a Quote |
| EIF4EBP1 Knockout HeLa Cell Line | EDJ-KQ20450 | Human | 1978 | Details Get a Quote |
Displaying Records 1 To 15 Of 32 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About eukaryotic initiation factor 4E binding
What is eukaryotic initiation factor 4E binding (GO:0008190)?
It is a molecular function defined as binding to eIF4E, the cap-binding protein involved in translation initiation.
What genes are involved in eukaryotic initiation factor 4E binding?
Key genes include EIF4E, EIF4EBP1/2/3, EIF4G1, EIF4A1 and MTOR, which together control eIF4E availability and complex assembly.
How is eIF4E binding regulated?
It is regulated by phosphorylation: mTORC1 phosphorylates 4E-BP1 to release eIF4E, and eIF4E phosphorylation acts as a switch for 4E-BP1 binding and cap assembly.
What is the role of 4E-BP1 in eIF4E binding?
4E-BP1 competes with eIF4G for eIF4E and represses cap-dependent translation; its phosphorylation by mTORC1 relieves this repression.
Why is eIF4E important in cancer?
4E-BP1 is a master regulator of translation in tumorigenesis, and eIF4E-driven cap-dependent translation supports oncogenic programs.
Is eIF4E phosphorylation always required for translation control?
No; eIF4E phosphorylation is dispensable for skeletal muscle hypertrophy, showing context-dependent requirements.
How can I study eIF4E binding in the lab?
Common methods include co-immunoprecipitation, cap-analog pull-down, phospho-specific western blotting, Ribo-seq and polysome profiling.
Can eIF4E be targeted by small molecules?
Yes, benzoxaboroles have been identified as structurally unique binders of eIF4E, demonstrating chemical tractability.
Does exercise affect eIF4E binding?
Yes, the distribution of eIF4E after resistance exercise is altered by shortening recovery periods.
What CRISPR models are useful for studying GO:0008190?
Knockout of EIF4EBP1 or EIF4E, point mutations at the binding interface or Ser209, tagged knock-in of EIF4E, and overexpression models are all informative.
Conclusion
GO:0008190, eukaryotic initiation factor 4E binding, captures a central molecular function in translation control: the physical association of proteins such as 4E-BP1 and eIF4G with eIF4E. This interaction is governed by phosphorylation switches and mTORC1 signaling, and it determines whether cap-dependent translation proceeds. Its dysregulation is linked to cancer and to physiological remodeling in muscle, and the interface is chemically tractable. Because the function is defined by binding rather than by a single downstream phenotype, rigorous causal testing requires precise genetic models. CRISPR knockout, point-mutation, knock-in and overexpression approaches, combined with Ribo-seq and phosphoproteomics, provide the tools needed to determine which eIF4E interactions matter in a given context.
References
- 1. Batool A et al.. 2019. Eukaryotic initiation factor 4E (eIF4E): A recap of the cap-binding protein.. J Cell Biochem 120(9):14201-14212 PMID: 31074051
- 2. Musa J et al.. 2016. Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis.. Oncogene 35(36):4675-88 PMID: 26829052
- 3. Izidoro MS et al.. 2022. Human eukaryotic initiation factor 4E (eIF4E) and the nucleotide-bound state of eIF4A regulate eIF4F binding to RNA.. J Biol Chem 298(10):102368 PMID: 35963437
- 4. Batool A et al.. 2020. Eukaryotic Initiation Factor 4E phosphorylation acts a switch for its binding to 4E-BP1 and mRNA cap assembly.. Biochem Biophys Res Commun 527(2):489-495 PMID: 32336547
- 5. Figueiredo VC et al.. 2019. Phosphorylation of eukaryotic initiation factor 4E is dispensable for skeletal muscle hypertrophy.. Am J Physiol Cell Physiol 317(6):C1247-C1255 PMID: 31596607
- 6. McKendrick L et al.. 1999. Translation initiation factor 4E.. Int J Biochem Cell Biol 31(1):31-5 PMID: 10216941
- 7. Combs JB et al.. 2026. Benzoxaboroles Are Structurally Unique Binders of Eukaryotic Translation Initiation Factor 4E.. J Am Chem Soc 148(28):29610-29616 PMID: 42424620
- 8. Takegaki J et al.. 2020. The distribution of eukaryotic initiation factor 4E after bouts of resistance exercise is altered by shortening of recovery periods.. J Physiol Sci 70(1):54 PMID: 33148163
